Janoshik · Supplied sample report
Retatrutide COA and test report #244383
Sample RT30 · 30 mg catalog specification · Batch BPS 581
Verified against the issuer record on 17 Nov 2026. Applies to this sample and batch only.

As printed on the supplied report
Sample and test record
- Report number
- #244383
- Sample
- Retatrutide RT30
- Batch
- BPS 581
- Client
- biopepsynlab.com
- Manufacturer field
- BioPepSynLab
- Testing ordered
- 16 Oct 2026
- Sample received
- 04 Nov 2026
- Analysis conducted
- 06 Nov 2026
Reported results
| Entry | Printed result |
|---|---|
| Retatrutide | 32.02 mg |
| Purity | 99.514% |
Report comment: No comment printed.
Reading this particular sample
Amount, purity and identity
The requested panel names Semaglutide, Tirzepatide and Retatrutide, while the results row identifies Retatrutide at 32.02 mg. This does not describe a three-compound blend. RT30 corresponds to the 30 mg catalog specification.
Purity is printed separately as 99.514%. This result belongs to sample RT30, batch BPS 581; it should not be assigned to other Retatrutide specifications or to a new order lot.
